Pressures is mounting on world leaders to back temporarily dropping vaccine patent protections, in order to boost global supply. So, why is Prime Minister Justin Trudeau reluctant to give Canada’s opinion on it? David Akin explains the international support and skepticism over the strategy.
- G20 summit looks to boost vaccine access, may sidestep push for patent waiver
- G20 leaders snub COVID-19 vaccine patent waiver, watering down WHO funding commitments
- U.K. will join international talks on COVID-19 vaccine patent waivers